Publications by authors named "Uwe M Pommerich"

Background: The initial theme of the PROGRESS framework for prognosis research is termed overall prognosis research. Its aim is to describe the most likely course of health conditions in the context of current care. These average group-level prognoses may be used to inform patients, health policies, trial designs, or further prognosis research.

View Article and Find Full Text PDF

Background And Objectives: To identify and summarize validated multivariable prognostic models for the Functional Independence Measure® (FIM®) at discharge from post-acute inpatient rehabilitation in adults with acquired brain injury (ABI).

Methods: This review was conducted based on the recommendations of the Cochrane Prognosis Methods Group and adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Three databases were systematically searched in May 2021 and updated in April 2022.

View Article and Find Full Text PDF

Introduction: The Six Spot Step Test has shown good psychometric properties in terms of validity and reliability in people with multiple sclerosis. Yet, the responsiveness and minimal important change are unknown. The objective was to investigate the responsiveness of the Six Spot Step Test against the perceived change of walking limitations and establish estimates for the minimal important change in people with multiple sclerosis.

View Article and Find Full Text PDF

Background: Multiple sclerosis (MS) onset is commonly observed in adults aged 20-50 years of age. The incidence rate of MS-onset after age 50, late-onset MS, has increased along with the observed overall increase in MS incidence rate in the past 60 years. In general, the aetiology of MS is largely acknowledged to involve a complex interrelation of environmental and modifiable lifestyle risk factors in genetically susceptible individuals.

View Article and Find Full Text PDF

Background: Fatigue is considered the most common symptom of persons with multiple sclerosis MS (pwMS), occurring in up to 90% of the patients at some point with two-thirds of pwMS experience fatigue as their most disturbing symptom. Pharmacological treatment options for MS-related fatigue show only limited and contradicting results. Consequently, many pwMS search for alternative options to control the symptom.

View Article and Find Full Text PDF